CPSF2 and prostate carcinoma: We also tested for gene expression associations with prostate cancer progression using TCGA data curated specifically for survival analysis.33 High expression of CPSF1 and PCF11 and low expression of CPSF2 and CSTF1 were associated with faster disease progression (Figures 2B–2E and S1C).